Abstract:<p>Protein ubiquitylation regulates almost all aspects of the biological processes including gene expression, DNA repair, cell proliferation and apoptosis in eukaryotic cells. Dysregulation of protein ubiquitylation caused by abnormal expression of enzymes in the ubiquitin system results in the onset of many diseases including cancer, neurodegenerative diseases, and metabolic syndromes. Therefore, targeting the ubiquitin system becomes a promising research area in drug discovery. Identification of protein ubiquitylation sites is critical for revealing the key ubiquitylation events associated with diseases and specific signaling pathways and for elucidating the biological functions of the specific ubiquitylation events. Many approaches that enrich for the ubiquitylated proteins and ubiquitylated peptides at the protein and peptide levels have been developed to facilitate their identification by MS. In this paper, we will review the proteomic approaches available for the identification of ubiquitylation events at the proteome scale and discuss their advantages and limitations. We will also brief the application of the profiling of ubiquitylation events in drug target discovery and in target validation for proteolysis-targeting chimera (PROTAC). Possible future research directions in this field will also be discussed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>Ubiquitylation plays critical roles in regulating many biological processes in eukaryotic cells. Identification of ubiquitylation sites can provide the essential information for the functional study of the specific modified substrates. Since ubiquitylated proteins have much lower abundance than non-ubiquitylated proteins, enrichment of ubiquitylated proteins or peptides is critical for their identification by MS. This review focuses on different enrichment approaches that facilitate their isolation and identification by MS and discusses the advantages and drawbacks of these approaches. The application of the profiling of ubiquitylation events in drug target discovery and future research directions will be beneficial to the research community.</p>

Integrative Proximal-Ubiquitomics Profiling for Deubiquitinase and E3 Ligase Substrate Discovery Applied to USP30

Discovery of potent and selective activity-based probes (ABPs) for the deubiquitinating enzyme USP30

Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale

Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes

A ubiquitin-specific, proximity-based labeling approach for the identification of ubiquitin ligase substrates

Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates

Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor

Comprehensive Profiling of Protein Ubiquitination for Drug Discovery

A Proteomic Approach for Systematic Mapping of Substrates of Human Deubiquitinating Enzymes

A Proteomics Strategy to Identify Substrates of LNX, a PDZ Domain Containing E3 Ubiquitin Ligase

Cell-Based Covalent-Capture Deubiquitinase Assay for Inhibitor Discovery

Deep-learning Based Approach to Identify Substrates of Human E3 Ubiquitin Ligases and Deubiquitinases.

USP7 Substrates Identified by Proteomics Analysis Reveal the Specificity of USP7.

Activity-Based Ubiquitin Probes for Investigation of Deubiquitinases

Abstract 3885: A ubiquitin-specific proximity labeling method to study drug-induced ubiquitylation

Variety in the USP deubiquitinase catalytic mechanism

Revealing USP7 Deubiquitinase Substrate Specificity by Unbiased Synthesis of Ubiquitin Tagged SUMO2

Proteomic approaches for the profiling of ubiquitylation events and their applications in drug discovery

Identifying the Substrate Proteins of E3 Ubiquitin Ligase by Orthogonal Ubiquitin Transfer (OUT)

Specific Substrate Recognition and Thioester Intermediate Determinations in Ubiquitin and Sumo Conjugation Cascades Revealed by A High-Sensitive Fret Assay

USP30: Structure, Emerging Physiological Role, and Target Inhibition